Business
Investor teach-in
Investor teach-in.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \nRNS Number : 4298X Avacta Group PLC 13 January 2014 \n \n\n \nAvacta Group plc\n(\"Avacta\" or the \"Group\")\n \nInvestor teach-in\n \nAvacta Group plc (AIM: AVCT), the global provider of proprietary diagnostic tools, consumables and reagents for human and animal healthcare, announces it will be hosting an investor teach-in on 5 February 2014 where Alastair Smith, CEO, will provide an overview of the Avacta business. No new material information will be disclosed.\n \nMatt Johnson, who recently joined Avacta from Abcam as the Head of Research & Development of Avacta's Life Sciences division, will discuss the opportunity for Affimers, Avacta's proprietary affinity reagent platform.\n \nThe event, which will include a demonstration and showcase of some of the Avacta's products, will be held from 16:30 until 19:30 in the Oriental Room at the London Capital Club, 15 Abchurch Lane, London, EC4N 7BW, followed by drinks and canapés.\n \nFor more information or to register to attend, contact Walbrook PR (contact details are below).\n \nEnquiries:\n \n\n\n\n\n \n\n\n \n\n\n\n\nWalbrook PR Limited\n\n\nTel: 020 7933 8780 or [email protected]\n\n\n\n\nAnna Dunphy\n\n\n Mob: 07876 741 001\n\n\n\n\nLianne Cawthorne\n\n\nMob: 07584 391 303\n\n\n\n\n \n \n \n \n \nAbout Avacta Group plc - www.avacta.com\n \nAvacta Group plc is a global provider of innovative technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. Avacta operates through three divisions:\n \n\n\n\n\nAvacta Analytical\nwww.avactaanalytical.com\n \n\n\nHigh throughput analysis instrument, Optim, to help reduce the cost and risk of drug development.\n\n\n\n\nAvacta Animal Health\nwww.avactaanimalhealth.com\n \n\n\nVeterinary diagnostics reference laboratory, diagnostic kits and newly launched in-clinic blood analyser, Sensipod.\n\n\n\n\nAvacta Life Sciences\nwww.avactalifescience...